EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Profiling Inhibitor Scaffolds for the Cancer Target Jumonji‐C Domain‐Containing Protein 6

Thomas P Corner, Eidarus Salah, Anthony Tumber, James P Holt-Martyn, Lennart Brewitz iD, Christopher J Schofield iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500682 ↗

At a glance

Journal article in ChemMedChem, 2025. Written by Thomas P Corner and 5 co-authors. Institution: Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield …. Major MEDLINE topics: Jumonji Domain-Containing Histone Demethylases, Enzyme Inhibitors, Antineoplastic Agents. Cited 6 times so far (Crossref); 127 references. The full text is freely available (open access, CC BY 4.0). Funded by: Cancer Research UK, Wellcome Trust, Biotechnology and Biological Sciences Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The human 2‐oxoglutarate‐dependent oxygenase Jumonji‐C domain‐containing protein 6 (JMJD6) catalyzes post‐translational C‐5 lysyl residue hydroxylation in multiple proteins. Aberrant JMJD6 catalysis is associated with the upregulation of androgen receptor splice variant 7 (AR‐V7), which confers resistance towards antiandrogens used for prostate cancer treatment; JMJD6 is thus a promising cancer target. To date, few small‐molecule JMJD6 inhibitors are reported, likely in part reflecting a lack of robust assays to monitor effects of small molecules on catalysis by isolated JMJD6. The use of solid‐phase extraction coupled to mass spectrometry assays is described to screen scaffolds for the development of selective JMJD6 inhibitors. The results reveal that the reported JMJD6 inhibitors WL12, SKLB325, and Compound 7p manifest relatively inefficient JMJD6 inhibition in vitro. By contrast, some, but not all, clinically used inhibitors of the human hypoxia‐inducible factor‐α prolyl hydroxylase domain‐containing proteins (PHDs) efficiently inhibit isolated JMJD6, in particular Enarodustat and Desidustat. The results identify attractive scaffolds for the development of selective, cell permeable JMJD6 inhibitors and suggest that JMJD6 inhibition is a potential off‐target effect of PHD inhibitors in clinical use.

Subjects

MeSH terms (MEDLINE)

Jumonji Domain-Containing Histone DemethylasesEnzyme InhibitorsAntineoplastic AgentsHumansStructure-Activity RelationshipMolecular StructureDose-Response Relationship, Drug

Author keywords

2‐oxoglutarate/α‐ketoglutarate‐dependent oxygenaseDesidustatEnarodustatJmjC hydroxylase inhibitionJumonji‐C domain‐containing protein 6bromodomain‐containing protein 4high‐throughput inhibition assaysinhibitor discoverymetastatic castration‐resistant prostate cancer

Substances

Jumonji Domain-Containing Histone DemethylasesJMJD6 protein, humanEnzyme InhibitorsAntineoplastic Agents

Authors and institutions

  • Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.

ORCID profiles: Lennart Brewitz, Christopher J Schofield

Funding

  • Cancer Research UK
  • Wellcome Trust
  • Biotechnology and Biological Sciences Research Council

Cite

APA

Corner, T. P., Salah, E., Tumber, A., Holt-Martyn, J. P., Brewitz, L., & Schofield, C. J. (2025). Profiling Inhibitor Scaffolds for the Cancer Target Jumonji‐C Domain‐Containing Protein 6. ChemMedChem. https://doi.org/10.1002/cmdc.202500682

Vancouver

Corner TP, Salah E, Tumber A, Holt-Martyn JP, Brewitz L, Schofield CJ. Profiling Inhibitor Scaffolds for the Cancer Target Jumonji‐C Domain‐Containing Protein 6. ChemMedChem. 2025. doi:10.1002/cmdc.202500682

BibTeX
@article{Corner2025,
  author = {Corner, Thomas P and Salah, Eidarus and Tumber, Anthony and Holt-Martyn, James P and Brewitz, Lennart and Schofield, Christopher J},
  title = {Profiling Inhibitor Scaffolds for the Cancer Target Jumonji‐C Domain‐Containing Protein 6},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500682}
}
Start for free →